| Dendritic cell–based immunotherapy: state of the art and beyond KF Bol, G Schreibelt, WR Gerritsen, IJM De Vries, CG Figdor Clinical cancer research 22 (8), 1897-1906, 2016 | 208 | 2016 |
| Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors JFM Jacobs, AJ Idema, KF Bol, S Nierkens, OM Grauer, P Wesseling, ... Neuro-oncology 11 (4), 394-402, 2009 | 194 | 2009 |
| Prognostic significance and mechanism of Treg infiltration in human brain tumors JFM Jacobs, AJ Idema, KF Bol, JA Grotenhuis, IJM de Vries, P Wesseling, ... Journal of neuroimmunology 225 (1-2), 195-199, 2010 | 178 | 2010 |
| Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination EHJG Aarntzen, IJM De Vries, WJ Lesterhuis, D Schuurhuis, JFM Jacobs, ... Cancer research 73 (1), 19-29, 2013 | 146 | 2013 |
| Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells G Schreibelt, KF Bol, H Westdorp, F Wimmers, EHJG Aarntzen, ... Clinical cancer research 22 (9), 2155-2166, 2016 | 139 | 2016 |
| Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients EHJG Aarntzen, G Schreibelt, K Bol, WJ Lesterhuis, S Croockewit, ... Clinical Cancer Research, clincanres. 3368.2012, 2012 | 97 | 2012 |
| Dendritic cell cancer therapy: vaccinating the right patient at the right time WW Van Willigen, M Bloemendal, WR Gerritsen, G Schreibelt, ... Frontiers in immunology 9, 2018 | 57 | 2018 |
| Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell based vaccination in metastatic melanoma EHJG Aarntzen, K Bol, G Schreibelt, JFM Jacobs, WJ Lesterhuis, ... Cancer research, canres. 2479.2012, 2012 | 52 | 2012 |
| Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination KF Bol, EHJG Aarntzen, FEM Hout, G Schreibelt, JHA Creemers, ... Oncoimmunology 5 (1), e1057673, 2016 | 51 | 2016 |
| Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients KF Bol, HW Mensink, EHJG Aarntzen, G Schreibelt, JEE Keunen, ... American journal of ophthalmology 158 (5), 939-947. e5, 2014 | 48 | 2014 |
| Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients KF Bol, CG Figdor, EHJG Aarntzen, MEB Welzen, MM van Rossum, ... Oncoimmunology 4 (8), e1019197, 2015 | 35 | 2015 |
| Naturally circulating dendritic cells to vaccinate cancer patients KF Bol, J Tel, IJM De Vries, CG Figdor Oncoimmunology 2 (3), e23431, 2013 | 34 | 2013 |
| Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity KF Bol, EHJG Aarntzen, JM Pots, MAMO Nordkamp, MWMM van de Rakt, ... Cancer Immunology, Immunotherapy 65 (3), 327-339, 2016 | 33 | 2016 |
| T-cell landscape in a primary melanoma predicts the survival of patients with metastatic disease after their treatment with dendritic cell vaccines A Vasaturo, A Halilovic, KF Bol, DI Verweij, WAM Blokx, CJA Punt, ... Cancer research, 2016 | 31 | 2016 |
| Adjuvant dendritic cell vaccination in high-risk uveal melanoma KF Bol, T Van den Bosch, G Schreibelt, HW Mensink, JEE Keunen, E Kiliç, ... Ophthalmology 123 (10), 2265-2267, 2016 | 21 | 2016 |
| Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients S Boudewijns, KF Bol, G Schreibelt, H Westdorp, JC Textor, ... Oncoimmunology 5 (7), e1191732, 2016 | 19 | 2016 |
| Immune-related adverse events of dendritic cell vaccination correlate with immunologic and clinical outcome in stage III and IV melanoma patients S Boudewijns, H Westdorp, RHT Koornstra, EHJG Aarntzen, G Schreibelt, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 39 (6), 241, 2016 | 19 | 2016 |
| Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity SV Hato, CG Figdor, S Takahashi, AE Pen, A Halilovic, KF Bol, A Vasaturo, ... Oncotarget 8 (33), 54434, 2017 | 15 | 2017 |
| Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination S Boudewijns, RHT Koornstra, H Westdorp, G Schreibelt, ... Oncoimmunology 5 (8), e1201625, 2016 | 12 | 2016 |
| Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy G Schreibelt, KF Bol, EHJG Aarntzen, WR Gerritsen, CJA Punt, CG Figdor, ... Oncoimmunology 2 (6), e24440, 2013 | 8 | 2013 |
